Literature DB >> 31679117

Cross talk between 26S proteasome and mitochondria in human mesenchymal stem cells' ability to survive under hypoxia stress.

Ramada R Khasawneh1, Ejlal Abu-El-Rub2,3, Abdullah Omar Serhan4, Bashar Omar Serhan4, Hadeel Abu-El-Rub5.   

Abstract

Mesenchymal stem cells (MSCs) are regarded as unique cells which play an imperative role in the field of regenerative medicine. They are characterized by the self-renewal capacity, multi-lineage differentiation abilities and immunomodulation properties which render them perfectly ideal cell type for treating a wide range of chronic diseases. Despite these enchanted features, there are many hurdles that need to be circumvented to ensure their long-term survival and viability after transplantation. Recently, hypoxia has been indicated as one of the most baffling stress conditions that can affect the survival rate of MSCs either positively or negatively depending on the level of hypoxia. MSCs can survive well under moderate hypoxia, but die shortly if they were exposed to severe hypoxia without clearly convincing explanation for this enigma. The current study reveals a novel mechanism of 26S proteasome in controlling the ability of BM-MSCs to withstand hypoxic stress by maintaining proper mitochondrial function. The results indicated that 26S proteasome remains functioning once BM- MSCs are exposed to moderate hypoxia (2.5%O2) and preserves their survival and proliferation mediated by intact mitochondrial performance, whereas 26S proteasome becomes inactive when BM-MSCs faces severe hypoxia that lead to poor mitochondrial function and less chance to survive longer. The outcomes of this study demonstrated the importance of 26S proteasome machinery in enhancing the resistance of BM-MSCs to hypoxic stress condition which may help in better planning future studies that target this system. Schematic representation summarizing the findings of the current study. 26S proteasome function preservation in normoxia and moderate hypoxia leads to maintain appropriate proliferation and mitochondrial activity in human BM-MSCs and promote their survival. On the opposite side, severe hypoxia disrupts the 26S proteasome function leading to significant reduction in the proliferation, survival and mitochondrial dynamics in human BM-MSCs causing their death.

Entities:  

Keywords:  Hypoxia; Mesenchymal stem cells; Mitochondria; Proteasome; Survival

Mesh:

Substances:

Year:  2019        PMID: 31679117     DOI: 10.1007/s12576-019-00720-6

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  50 in total

Review 1.  Structure and Function of the 26S Proteasome.

Authors:  Jared A M Bard; Ellen A Goodall; Eric R Greene; Erik Jonsson; Ken C Dong; Andreas Martin
Journal:  Annu Rev Biochem       Date:  2018-04-13       Impact factor: 23.643

2.  High throughput screening reveals no significant changes in protein synthesis, processing, and degradation machinery during passaging of mesenchymal stem cells 1.

Authors:  Glen Lester Sequiera; Niketa Sareen; Vikram Sharma; Arun Surendran; Ejlal Abu-El-Rub; Amir Ravandi; Sanjiv Dhingra
Journal:  Can J Physiol Pharmacol       Date:  2018-11-13       Impact factor: 2.273

3.  Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27.

Authors:  Sanjay Kumar; Meenal Vaidya
Journal:  Mol Cell Biochem       Date:  2016-02-26       Impact factor: 3.396

4.  Hypoxia-induced lowered executive function depends on arterial oxygen desaturation.

Authors:  Genta Ochi; Yusuke Kanazawa; Kazuki Hyodo; Kazuya Suwabe; Takeshi Shimizu; Takemune Fukuie; Kyeongho Byun; Hideaki Soya
Journal:  J Physiol Sci       Date:  2018-03-13       Impact factor: 2.781

5.  Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells.

Authors:  Caterina Fotia; Annamaria Massa; Filippo Boriani; Nicola Baldini; Donatella Granchi
Journal:  Cytotechnology       Date:  2014-05-06       Impact factor: 2.058

6.  Phorbol 12-myristate 13-acetate (PMA) suppresses high Ca2+-enhanced adipogenesis in bone marrow stromal cells.

Authors:  Ryota Hashimoto; Yuki Miyamoto; Seigo Itoh; Hiroyuki Daida; Takao Okada; Youichi Katoh
Journal:  J Physiol Sci       Date:  2019-06-29       Impact factor: 2.781

Review 7.  Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.

Authors:  Stephen M Richardson; Gauthaman Kalamegam; Peter N Pushparaj; Csaba Matta; Adnan Memic; Ali Khademhosseini; Reza Mobasheri; Fabian L Poletti; Judith A Hoyland; Ali Mobasheri
Journal:  Methods       Date:  2015-09-15       Impact factor: 3.608

8.  Hypoxia Augments Increased HIF-1α and Reduced Survival Protein p-Akt in Gelsolin (GSN)-Dependent Cardiomyoblast Cell Apoptosis.

Authors:  Yu-Lan Yeh; Wei-Jen Ting; Chia-Yao Shen; Hsi-Hsien Hsu; Li-Chin Chung; Chuan-Chou Tu; Sheng-Huang Chang; Cecilia-Hsuan Day; Yuhsin Tsai; Chih-Yang Huang
Journal:  Cell Biochem Biophys       Date:  2016-05-18       Impact factor: 2.194

9.  Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.

Authors:  Ruenn Chai Lai; Soon Sim Tan; Bao Ju Teh; Siu Kwan Sze; Fatih Arslan; Dominique P de Kleijn; Andre Choo; Sai Kiang Lim
Journal:  Int J Proteomics       Date:  2012-07-18

10.  Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.

Authors:  Hanneke Stegeman; Johannes H Kaanders; Deric L Wheeler; Albert J van der Kogel; Marieke M Verheijen; Stijn J Waaijer; Mari Iida; Reidar Grénman; Paul N Span; Johan Bussink
Journal:  BMC Cancer       Date:  2012-10-10       Impact factor: 4.430

View more
  1 in total

1.  Oct4-dependent FoxC1 activation improves the survival and neovascularization of mesenchymal stem cells under myocardial ischemia.

Authors:  Zhou Ji; Songsheng Chen; Jin Cui; Weiguang Huang; Rui Zhang; Jianrui Wei; Shaoheng Zhang
Journal:  Stem Cell Res Ther       Date:  2021-08-28       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.